Al Hikma Pharmaceuticals
Last Updated:
- 70.100 USD
- 0.000
- 0.00%
الحكمة للصناعات الدوائية
الحكمة
Symbol :
HIK
ISIN :
US4312882081
52-Week Range :
0.000
-
70.100
Turnover Ratio :
0.00
Market :
Nasdaq Dubai
Sector :
--
Industry :
Pharmaceuticals
Sub-Industry :
Basic Information
-
Activity :Hikma Pharmaceuticals PLC (knwon as:Hikma) is a public company, listed on Nasdaq Dubai since April 2006. Hikma operates within the Pharmaceuticals, Biotechnology & Life Sciences sector focusing on Pharmaceuticals....
-
Industry Group :Pharmaceuticals, Biotechnology & Life Sciences
-
Sub-Industry :
-
ISIN :US4312882081
-
Contact Person :
-
Established On:08-Sep-2005
-
Stock Listing On :26-Apr-2006
-
No of Employees :--
-
Outstanding Shares :234,719,686
-
Free Float Shares :
-
Par Value :
-
Paid Capital :
-
Market Cap :
-
Authorized Capital :
Indices Membership
Data Not Available
| Hikma Pharmaceuticals PLC |
| 1 New Burlington Place, London W1S 2HR |
| T : +44 20 73992760 |
| F : +44 20 73992761 |
| www.hikma.com |
| djadeja@hikma.com |
Management
| Title | Name | As Of |
|---|---|---|
| Chairman: | Said Darwazah | 2014 |
| CEO: | Riad Mishlawi | |
| Board Member: | Mazen Darwazah | 2005 |
| Ali Al Husry | 2005 | |
| Nina Henderson | 2017 | |
| Cynthia Schwalm | 2019 | |
| Victoria Hull | ||
| Douglas Hurt | 2020 | |
| Laura Balan | ||
| Deneen Vojta |
Reports
| Date | Title | File |
|---|---|---|
| 2019 | Hikma Pharmaceuticals Annual Financials Report 2018 | |
| 2019 | Hikma delivers strong 2018 results and makes good strategic progress to position for future growth | |
| 2018 | Hikma reports strong 2018 interim results and raises full year guidance | |
| 2018 | Hikma reports 2017 full year results | |
| 2017 | Al Hikma Pharmaceutical Company achieves strong financial performance and strategic progress in 2016 | |
| 2016 | Hikma Pharmaceuticals Annual Financials Report 2015 | |
| 2016 | Hikma Pharmaceuticals Annual Financials Report 2015 | |
| 2015 | North Africa Holding to fully exit from EIMC United Pharma | |
| 2015 | Hikma Pharmaceuticals Quarterly Financials Report Q2 2015 | |
| 2015 | Hikma acquires Roxane Laboratories | |
| 2015 | Hikma Pharmaceuticals PLC Voting Rights and Capital |
